baber/WOPTO huggingface dataset:
Patent NZ-555146-A (NZ)
Title: An SNCR distribution grid for delivering a reactant for reducing NOx into a gas stream containing NOx
Inventor: MARYAMCHIK MIKHAIL
IPC: B01J19/26
Filed: 2005-11-10
Abstract: An SNCR distribution grid for delivering a reactant for reducing NOx into a gas stream containing NOx is disclosed. The SNCR distribution grid comprises at least one element for conveying the reactant from a source outside of the gas stream. The element has at least one nozzle for spraying the reactant from a conduit defined within the element into the gas stream. The conduit is formed by at least two fluid-cooled tubes and membranes located in-between the tubes and the nozzle is located in at least one of the membranes. The at least one element is provided with a protective tile where the protective tile is provided with a spacer to provide a gap between the protective tile and the membrane for reducing heat absorption by the membrane. The spacer is provided with a portion which extends around the nozzle and a portion which extends within an aperture in the protective tile to prevent excessive movement of the protective tile during operation.
Patent NZ-564204-A (NZ)
Title: Hydraulic circuit for power tong, with pump cylinder articulately connected between drive rings and rotatable therewith
Inventor: VATNE PER A
IPC: F15B/
Filed: 2006-06-02
Abstract: A hydraulic circuit device for activating the at least one clamping die (14) of a power tong (1), the power tong (1) including two housing halves (2), pivotable relative to each other, the housing halves (2) being arranged to be pivoted between a closed, active position and an open, inactive position, and a radially divided drive ring (6, 8) which is provided with the at least one hydraulically activated clamping die (14) directed towards the centre axis (10) of the power tong (1), being placed in the housing halves (2), the drive ring (6, 8) being supported and connected to at least one driving motor (12) for the rotation of the drive ring (6, 8) about the centre axis (10), and a hydraulic pump cylinder (16) being articulatedly connected between the first drive ring part (6) of the drive ring (6, 8) and the second drive ring part (8) of the drive ring (6, 8); and arranged to rotate together with the drive ring (6, 8) about the centre axis (10).
Patent NZ-565002-A (NZ)
Title: (R/S) Rifamycin derivatives, their preparation and pharmaceutical compositions
Inventor: LONGGOOD JAMIE CAROL
IPC: C07D498/08
Filed: 2005-07-21
Abstract: Disclosed are rifamycin derivatives having the general structure of formula (I) (both hydroquinone and corresponding quinone (C1-C4) forms): or its salts, or hydrates thereof; wherein a preferred R1 comprises hydrogen or acetyl and a preferred R2 comprises hydrogen, methyl or other lower alkyls; wherein asterisk (*) denotes the carbon bearing the chiral centre, wherein absolute configuration is assigned as R or S. Further disclosed are methods for the preparation of the aforementioned compounds. The compounds exhibit antimicrobial activities, including activities against drug-resistant microorganisms.
Patent NZ-567102-A (NZ)
Title: Optical device for led light sources
Inventor: ZWEIG FREDERIC
IPC: G02B6/00
Filed: 2006-10-02
Abstract: Disclosed is an optical device for the targeted reproduction of light emitted by LED light sources (6). The optical device comprises at least two component parts, a first optical component part (10) in the form of a solid waveguide and another component part for connection to the LED light source. In a system of Cartesian co-ordinates, the first optical component part (10) has a length in the y direction shorter than or equal to its length in the z direction and shorter than or equal to its length in the x direction. The first part comprises: first and second planar outer surfaces opposing in the x-z plane; third and fourth planar or nonplanar outer surfaces substantially opposing on the x-y plane; and fifth and sixth opposing outer surfaces curved in a convex manner with regard to the y-z plane. The third and fourth outer surfaces are square, and the fifth and sixth outer surfaces are curved such that the fourth outer surface has a length in the x·direction that is smaller than the length of the third outer surface.
Patent NZ-568551-A (NZ)
Title: Human monoclonal antibodies to Fucosyl-GM1 and methods using anti-Fucosyl-GM1
Inventor: VISTICA CYNTHIA A
IPC: A61P35/00
Filed: 2006-12-08
Abstract: Disclosed are human monoclonal antibodies that specifically bind to Fucosyl-GM1. The antibodies can be used to treat cancer, in particular non-small cell lung cancer.
Patent NZ-571769-A (NZ)
Title: Stabilization of dicarbonate diesters with phosphorus compounds
Inventor: KAHLERT STEFFEN
IPC: A23L29/00
Filed: 2007-04-11
Abstract: Disclosed is the use of at least one phosphorus compound selected from phosphorus oxides, phosphorus-oxygen acids and derivatives thereof, or compounds which hydrolyse in situ to form phosphorus oxides, phosphorus-oxygen acids and derivatives thereof, for stabilization of diesters of dicarbonic acid against chemical and thermal breakdown reactions. Also discloses is mixtures comprising these phosphorous compounds and diesters and a method for purification of these diesters comprising the said phosphorous compounds.
Patent NZ-580223-A (NZ)
Title: A method and apparatus for seamless handover in a wireless communication network
Inventor: MEYER MICHAEL
IPC: H04L1/18
Filed: 2008-04-23
Abstract: In a wireless communication network where base stations receive protocol data units from mobile stations for ordered, sequential transfer as service data units to an associated core network, a method and a target base station supporting seamless handover of a mobile station from a source base station to the target base station are disclosed. The target base station (16-2) comprises an interface operative to receive service data units and sequence number information forwarded from the source base station and a handover processor. The forwarded service data units comprise those service data units being held at the source base station for sequential transfer to the associated core network and the forwarded sequence number information indicates sequence numbers corresponding to the forwarded service data units. The handover processor is operative to reorder the forwarded service data units as needed at the target base station for sequential transfer from the target base station to the associated core network. The mobile station (20) for use in a wireless communication network is also disclosed. The mobile station transmits protocol data units to a base station and the base station transfers corresponding service data units to an associated core network. The mobile station is configured for supporting seamless handover from a source base station to a target base station, and comprises a handover processor that is operative to regenerate new protocol data units for missing service data units and transmit the regenerated protocol data units responsive to signalling from the target base station that indicates which service data units are missing at the target base station or equivalently indicates which service data units have been successfully received, where the regenerated protocol data units are regenerated from corresponding service data units buffered at the mobile station. In a wireless communication network where base stations receive protocol data units from mobile stations for decompression and deciphering for ordered, sequential transfer as service data units to an associated core network, a source base station (16-1) for supporting seamless handover of a mobile station from the source base station to a target base station is disclosed. The source base station comprises a handover processor and an associated interface for forwarding from the source base station to the target base station service data units and sequence number information. The forwarded service data units comprise those service data units being held at the source base station for sequential transfer to the associated core network and the forwarded sequence number information indicates sequence numbers corresponding to the forwarded service data units.
Patent NZ-581253-A (NZ)
Title: Variable height baby carrying device
Inventor: PETRA SCHACHTNER
IPC: A47D13/02
Filed: 2008-04-22
Abstract: A carrying device with a receiving body for receiving a baby or small child. The receiving body receives and supports the rear side of the baby or small child. A holding harness system fastens the receiving body to a person. The height of the receiving body can be changed. The receiving body is formed from a single piece of material and has a main section, an extension section arranged above the main section, and an end section arranged above the extension section. The receiving body is extendable in the vertical direction by the extension element.
Patent NZ-583653-A (NZ)
Title: Bottle Crusher with hammer mill and recess in drum for reduced pressure at feed inlet
Inventor: BARNETT TIMOTHY JAMES FULTON
IPC: B02C13/00
Filed: 2010-03-02
Abstract: A bottle crusher has rotating hinged hammers and a void indentation 36 in the drum so as to cause a reduced pressure at the feed inlet, when in use.
Patent NZ-588689-A (NZ)
Title: 1-oxo-8-fluoro-isoquinolinone derivatives as nk3 antagonists
Inventor: KHANZHIN NIKOLAY
IPC: A61K31/472
Filed: 2009-04-22
Abstract: Disclosed are 1-oxo-8-fluoro-isoquinoline derivatives as represented by the general formula [Ik], wherein wherein R1 represents ethyl, cyclopropyl or cyclobutyl; R12 represents fluoro; and R13, R14 and R15 each individually represent hydrogen, fluoro or chloro, wherein two of R13, R14 and R15 represent hydrogen. Further disclosed is a compound as defined above for use in the treatment of a disease selected from psychosis; schizophrenia; schizophrenoform disorder; schizoaffective disorder; delusional disorder; brief psychotic disorder; shared psychotic disorder; psychotic disorder due to a general medical condition; substance or drug induced psychotic disorder (cocaine, alcohol, amphetamine etc); schizoid personality disorder; schizoptypal personality disorder; psychosis or schizophrenia associated with major depression, bipolar disorder, Alzheimer's disease or Parkinson's disease; major depression; general anxiety disorder; bipolar disorder (maintenance treatment, recurrence prevention and stabilization); mania; hypomania; cognitive impairment; ADHD; obesity; appetite reduction; Alzheimer's disease; Parkinson's disease; pain; convulsions; cough; asthma; aIrway hyperresponsiveness; microvascular hypersensitivity; bronchoconstriction; chronic obstructive pulmonary disease; urinary incontinence; gut inflammation; and inflammatory bowel syndrome.
Patent NZ-592832-A (NZ)
Title: Beauveria bassiana fungus strain K4B3
Inventor: FORD STEPHEN REYNOLD
IPC: A01N63/30
Filed: 2009-10-09
Abstract: Disclosed is a biologically pure culture of Beauveria bassiana fungus strain K4B3 on deposit at the National Measurement Institute of Australia under accession no. V08/025855.
Patent NZ-595663-A (NZ)
Title: Immediate release pharmaceutical compositions comprising oxycodone and naloxone
Inventor: DANAGHER HELEN KATHLEEN
IPC: A61K9/20
Filed: 2010-03-10
Abstract: 595663 Disclosed herein is an oral immediate release pharmaceutical composition comprising at least oxycodone or a pharmaceutically acceptable salt thereof and naloxone or a pharmaceutically acceptable salt thereof in about a 2:1 ratio (oxycodone or a pharmaceutically acceptable salt thereof: naloxone or a pharmaceutically acceptable salt thereof) by weight, wherein the formulation releases in vitro, when measured using the Ph. Eur. Paddle Method at 100 rpm in 0.1 N hydrochloric acid at 37°C and using UV detection at 230 nm, > 75% of oxycodone or a pharmaceutically acceptable salt thereof by weight and > 75 % of naloxone or a pharmaceutically acceptable salt thereof by weight at 45 min, and the use thereof in the treatment of pain.
Patent NZ-595726-A (NZ)
Title: Compositions and methods for treatment of aortic fibrosis
Inventor: DUGGAN KAREN ANNETTE
IPC: A61K38/04
Filed: 2010-04-06
Abstract: 595726 COMPOSITIONS AND METHODS FOR TREATMENT OF AORTIC FIBROSIS Provided is the use of vasoactive intestinal peptide (VIP) with a specified sequence or one or more functional fragments thereof for the manufacture of a medicament for the prophylactic or therapeutic treatment of aortic fibrosis.
Patent NZ-595886-A (NZ)
Title: Product for the storage of freeze-dried lactic acid bacteria mixed with a powder for an oral rehydration solution
Inventor: LUNDQVIST CHRISTOFFER
IPC: A23L1/30
Filed: 2010-07-09
Abstract: 595886 Disclosed is a probiotic product, comprising freeze-dried lactic acid bacteria, or other product that is sensitive to moisture, mixed with anhydrous oral rehydration solution powder, the composition packaged in a foil having desiccant integrated in the foil.
Patent NZ-598074-A (NZ)
Title: Novel antibacterial hydroxyphenyl compound
Inventor: GERUSZ VINCENT
IPC: C07C255/54
Filed: 2009-11-11
Abstract: 598074 The disclosure relates to a novel hydroxyphenyl compound, 4-(4-ethyl-5-fluoro-2-hydroxyphenoxy)-3-fluorobenzamide, to the preparation of the compound and intermediates used therein, to the use of the compound as an antibacterial medicament and pharmaceutical compositions containing the compound. Infections which may be treated with the disclosed compound includes infections caused by the organisms methicillin-susceptible Staphylococcus aureus (MSSA), methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin resistant Staphylococcus aureus (VRSA) strains, Acinetobacter baumannii, Bacillus anthracis, Chlamydophila pneumoniae, Escherichia coli, Haemophilus influenzae, Helicobacter pylori, Klebsiella pneumoniae, Neisseria meningitidis, S. intermedius, P. multocida, B. bronchiseptica, M. haemolytica and A. pleuropneumoniae, and also bacteria such as Mycobacterium tuberculosis or other organisms such as Plasmodium falciparum.
Patent NZ-609816-A (NZ)
Title: 4-substituted-3-phenylsulfanylmethyl-bicyclo[3.1.0]hexane compounds as mglur 2/3 antagonists
Inventor: SMITH STEPHON CORNELL
IPC: A61K31/10
Filed: 2011-11-15
Abstract: Disclosed are a family of mGluR 2/3 receptor antagonists with the general formal as shown in the abstract image and wherein R1, R2, R3 and R4 are as disclosed within the specification. These 4-substituted-3-phenylsulfanylmethyl-bicyclo[3.1.0]hexane compounds can be used for the treatment of depressive disorders and excessive sleepiness. Example compounds include: (1S,2R,3S,4S,5R,6R)-2-amino-3-{ [(3,4-difluorophenyl)sulfanyl]methyl} -4-hydroxybicyclo[3.1.0]hexane-2,6-dicarboxylic acid, bis({ [(1-methylethoxy)carbonyl]oxy} methyl) (1S,2R,3S,4S,5R,6R)-2-amino-3-{ [(3,4-difluorophenyl)sulfanyl]methyl} -4-hydroxybicyclo[3.1.0] hexane-2,6-dicarboxylate (1S,2R,3S,4S,5R,6R)-2-amino-3-{ [(3-chloro-4-fluorophenyl)sulfanyl]methy} -4-hydroxybicyclo[3.1.0] hexane-2,6-dicarboxylic acid, bis({ [(1-methylethoxy)carbonyl]oxy} methyl) (1S,2R,3S,4S,5R,6R)-2-amino-3-{ [(3-chloro-4-fluorophenyl)sulfanyl]methyl} -4-hydroxybicyclo[3.1.0]hexane-2,6-dicarboxylate.
Patent NZ-614366-A (NZ)
Title: Methods and compositions for preparing noribogaine from voacangine
Inventor: MASH DEBORAH C
IPC: C07D487/18
Filed: 2012-01-23
Abstract: The disclosure relates to a method for preparing and purifying noribogaine which method comprises: (a) covalently attaching voacangine to a solid support via the indole nitrogen of voacangine so as to form a suspension of solid supports having voacangine bound thereto; (b) converting voacangine to 12-hydroxyibogamine-18-carboxylic acid methyl ester, 12-hydroxyibogamine-18-carboxylic acid or the carboxylic acid salt thereof under conditions wherein the level of voacangine bound to the solid support is less than 0.1 weight percent; (c) cleaving and recovering 12-hydroxyibogamine-18-carboxylic acid methyl ester, 12-hydroxyibogamine-18-carboxylic acid or the carboxylic acid salt thereof from the solid support; (d) converting the 12-hydroxyibogamine-18-carboxylic acid methyl ester, 12-hydroxyibogamine-18-carboxylic acid or the carboxylic acid salt thereof to noribogaine; and (e) isolating and purifying noribogaine.
Patent NZ-618928-A (NZ)
Title: Isolation system for drilling systems
Inventor: ABLE ROBERT EUGENE
IPC: E21B49/08
Filed: 2009-10-13
Abstract: A vibration isolation system (200) for a drill head (110) is disclosed. Isolating a drill mast or rig from vibratory energy can help keep the rig structure from fatigue cracking over time and generally wearing out. The system includes at least one air bladder assembly including at least one air bladder and at least one coupling member coupling the air bladder to a drill head, wherein the air bladder is configured to compress and expand to counter oscillating forces generated by the drill head.
Patent NZ-623511-A (NZ)
Title: An inflatable cavity fill or cavity forming member
Inventor: ANDREW LEO HAYNES
IPC: F16K17/00
Filed: 2013-04-05
Abstract: 623511 Disclosed is a device (100) for filling or creating a void within a construction medium, such as concrete, to permit the passage or installation of pipes (200) or fittings. The device (100) comprises a body and at least one valve member (140). The body has at least one inflatable body portion. Each inflatable body portion has one or more inflatable cavities (111a-111m). The at least one valve member (140) fluidly connects to the one or more inflatable cavities (111a-111m) to control flow of fluid into the one or more inflatable cavities (111a-111m) to inflate. In use, the one or more cavities (111a-111m) are shaped to substantially fill or create the void in the construction medium when in an inflated state.
Patent NZ-625974-A (NZ)
Title: Stem cell for therapeutic use which is derived from human monocyte, and method for inducing same
Inventor: ISHIYAMA HIRONOBU
IPC: C12N5/078
Filed: 2009-11-19
Abstract: Disclosed are stem cells obtained by culturing monocytes in the presence of (i) M-CSF and (ii) at least one member selected from the group consisting of ganglioside and water-soluble plant derived extract extracted by the Folch extraction method, thereby dedifferentiating the monocytes, wherein the CXCR4 expression of the stem cells is more than three or four times greater compared with stem cells obtained by culturing monocytes in the presence of M-CSF and IL-3 and the CXCR4 expression of the stem cells is more than two or three times greater compared with bone marrow derived mesenchymal stem cells.
Patent NZ-630758-A (NZ)
Title: Method and preparation system for preparing a brewed product
Inventor: DEUBER LOUIS
IPC: B65D85/804
Filed: 2013-04-03
Abstract: Disclosed is a coffee beverage brewing method to provide an improved brew flavour. The method comprises the steps of providing the capsule (1) as a closed capsule with a capsule wall, which has a covering surface on the extraction side and a covering surface on the injection side and a circumferential lateral surface extending between the extraction-side covering surface and the injection-side covering surface, introducing the capsule into a brewing module with an injector for introducing a brewing liquid into the capsule and a discharging device for discharging a brewed product, wherein the injector comprises at least one injection-side perforation element (12) and the discharging device comprises at least one extraction-side perforation element, closing a brewing chamber of the brewing module so that the at least one injection-side perforation element pierces the injection-side covering surface along a cutting line, introducing under pressure a brewing liquid into the region between the injection-side supporting surface and the injection-side covering surface, in such a manner that the pressure of the liquid causes the extraction-side covering surface to be displaced towards the interior of the capsule whilst an encompassing capsule seal (43) holds the circumferential lateral surface, and brewing liquid enters the capsule interior, and maintaining the pressure on the brewing liquid at least until the brewed product emerges from discharge openings produced in the extraction-side covering surface as a result of piercing by the at least one extraction-side perforation element.
Patent NZ-707649-A (NZ)
Title: Bottle with insulative body
Inventor: KISELA DAVID
IPC: B65D81/38
Filed: 2014-02-04
Abstract: A bottle (120, 220, 320, 420) includes a base (122), a neck (128), and a body (124) extending axially between the base and the neck, and including at least one radially outwardly facing first surface (134a, 134b), a radially outwardly facing second surface (146, 346, 446) radially smaller than the first surface, a radially outwardly facing third surface (150, 250, 350, 450) radially larger than the second surface and established collectively by radially outwardly facing projection surfaces (154, 254, 354, 454) of a plurality of projections (152, 252, 352, 452) that project radially outwardly from the third surface. A label (160) may be carried by the body over at least a portion of the third surface. Axial and circumferential space may be established between the label and the second surface. The bottle provides an insulative volume to provide reduced heat transfer from a user’s hand to the contents of the bottle, compared to standard bottles.
Patent NZ-711257-A (NZ)
Title: Nucleic acid purification
Inventor: SELDEN RICHARD F
IPC: G01N1/34
Filed: 2010-02-03
Abstract: Disclosed is a self-contained apparatus for isolating nucleic acid from a biological sample. The self-contained apparatus may be a cartridge. The self-contained apparatus is to be used with an instrument. The self-contained apparatus comprises a macrofluidic component (3) and a microfluidic component (4) in communication with the macrofluidic component via at least one microfluidic element and at least one drive line. The microfluidic component (4) further includes a nucleic acid purification matrix. The macrofluidic component comprises a sample chamber (see 16, figure 4), for receiving an unprocessed biological sample from a collection device (1), at least one pre-filled reagent storage chamber (see 11, figure 4) pre-filled with lysis reagent, at least one wash reagent storage chamber (see 6 and/or 15, figure 4) pre-filled with wash reagent, an elution reagent storage chamber (see 9, figure 4) pre-filled with elution reagent, and at least one empty holding chamber (see 14, figure 4). The self-contained apparatus comprises two inputs; the first of which receives the sample from a collection device, and the second of which is a port for interfacing with a drive mechanism on the instrument via the drive line. The drive mechanism on the instrument is configured to drive the lysis reagents, wash reagent, elution reagent and combinations thereof sequentially through the microfluidic element and nucleic purification matrix and back into the holding chamber. In use, spent lysis, wash and elution reagents and combinations thereof are driven through the microfluidic element and back into the sample chamber, which also serves as a waste chamber for spent process reagents. The self-contained apparatus provides a simple means for isolating nucleic acid that eliminates the need for trained, technical users, working in sophisticated laboratories. Also, as the reagents are contained within the apparatus the risk of a user contaminating the reagent is avoided. A method for purifying nucleic acids from an unprocessed sample is also disclosed.